Use of Life-Sustaining Therapies for Patients With Ebola Virus Disease.

Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med (2014) 2.19

Use of Life-Sustaining Therapies for Patients With Ebola Virus Disease. Ann Intern Med (2015) 1.07

The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med (2010) 9.59

Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med (2005) 8.25

Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol (2006) 5.40

A randomized trial of nighttime physician staffing in an intensive care unit. N Engl J Med (2013) 4.94

Principles for allocation of scarce medical interventions. Lancet (2009) 4.55

Ethical issues concerning research in complementary and alternative medicine. JAMA (2004) 4.48

The obligation to participate in biomedical research. JAMA (2009) 4.34

Nighttime intensivist staffing, mortality, and limits on life support: a retrospective cohort study. Chest (2015) 3.77

Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med (2002) 3.62

Shared decision making to improve care and reduce costs. N Engl J Med (2013) 3.48

The cost of marginal medicine is too high. MedGenMed (2005) 3.33

Deceased organ donation consent rates among racial and ethnic minorities and older potential donors. Crit Care Med (2013) 3.22

Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA (2005) 3.14

The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06

Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ (2008) 2.84

Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol (2006) 2.72

Variation in decisions to forgo life-sustaining therapies in US ICUs. Chest (2014) 2.69

Survival differences following lung transplantation among US transplant centers. JAMA (2010) 2.57

Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol (2004) 2.52

Medicare's requirement for research participation as a condition of coverage: is it ethical? JAMA (2006) 2.43

Research with stored biological samples: what do research participants want? Arch Intern Med (2005) 2.43

Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42

The prognosis for changes in end-of-life care after the Schiavo case. Health Aff (Millwood) (2005) 2.40

Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29

Ethics of phase 1 oncology studies: reexamining the arguments and data. JAMA (2003) 2.28

A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med (2010) 2.25

The epidemiology of intensive care unit readmissions in the United States. Am J Respir Crit Care Med (2012) 2.23

Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19

Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med (2014) 2.19

Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med (2011) 2.18

US health aid beyond PEPFAR: the Mother & Child Campaign. JAMA (2008) 2.17

The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16

Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01

Turning wrong into right: the 2013 lung allocation controversy. Ann Intern Med (2013) 1.98

The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health (2004) 1.88

ICU occupancy and mechanical ventilator use in the United States. Crit Care Med (2013) 1.87

The patents-based pharmaceutical development process: rationale, problems, and potential reforms. JAMA (2005) 1.83

An Observational Study of Decision Making by Medical Intensivists. Crit Care Med (2015) 1.83

The ethics of paying for children's participation in research. J Pediatr (2002) 1.80

What is a "minor" increase over minimal risk? J Pediatr (2005) 1.79

Participants in phase 1 oncology research trials: are they vulnerable? Arch Intern Med (2008) 1.74

The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.72

Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol (2008) 1.71

Will physicians lead on controlling health care costs? JAMA (2013) 1.71

Objective factors associated with physicians' and nurses' perceptions of intensive care unit capacity strain. Ann Am Thorac Soc (2014) 1.68

Health care reform and cost control. N Engl J Med (2010) 1.66

A scenario-based, randomized trial of patient values and functional prognosis on intensivist intent to discuss withdrawing life support. Crit Care Med (2014) 1.66

Ethics. The ethics of international research with abandoned children. Science (2007) 1.65

Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol (2007) 1.65

Why patients continue to participate in clinical research. Arch Intern Med (2008) 1.62

Sex and haemodynamics in pulmonary arterial hypertension. Eur Respir J (2013) 1.61

Outcomes among patients discharged from busy intensive care units. Ann Intern Med (2013) 1.59

Shaping patients' decisions. Chest (2011) 1.58

Ending concerns about undue inducement. J Law Med Ethics (2004) 1.55

Mortality among patients admitted to strained intensive care units. Am J Respir Crit Care Med (2013) 1.53

Health care reform: why? What? When? Health Aff (Millwood) (2005) 1.50

Regional ethics organizations for protection of human research participants. Nat Med (2004) 1.48

Rationing in the intensive care unit: to disclose or disguise? Crit Care Med (2012) 1.48

Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med (2008) 1.47

Improving access to health care: a consensus ethical framework to guide proposals for reform. Hastings Cent Rep (2007) 1.47

Access and ability to pay: the ethics of a tiered health care system. Arch Intern Med (2007) 1.46

A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med (2013) 1.45

An empirical comparison of key statistical attributes among potential ICU quality indicators. Crit Care Med (2014) 1.43

Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42

Avoiding low-value care. N Engl J Med (2014) 1.41

Can the United States buy better advance care planning? Ann Intern Med (2014) 1.41

Perceptions of organ donation after circulatory determination of death among critical care physicians and nurses: a national survey. Crit Care Med (2012) 1.41

ASCO core values. J Clin Oncol (2006) 1.40

Quality-improvement research and informed consent. N Engl J Med (2008) 1.40

Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther (2009) 1.40

Does random treatment assignment cause harm to research participants? PLoS Med (2006) 1.39

The transparency imperative. Ann Intern Med (2013) 1.39

The moral duty to buy health insurance. JAMA (2012) 1.38

Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl (2011) 1.37

Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol (2002) 1.37

Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med (2014) 1.35

Hospital-based acute care use in survivors of septic shock. Crit Care Med (2015) 1.34

Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation (2011) 1.19

Tier 4 drugs and the fraying of the social compact. N Engl J Med (2008) 1.16

An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely® Top 5 list in Critical Care Medicine. Am J Respir Crit Care Med (2014) 1.15

The quality of informed consent in a clinical research study in Thailand. IRB (2005) 1.13

Twenty-four-hour intensivist staffing in teaching hospitals: tensions between safety today and safety tomorrow. Chest (2012) 1.12

PEPFAR and maximizing the effects of global health assistance. JAMA (2012) 1.12

Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. JAMA (2013) 1.11

Evaluating the risks of clinical research. JAMA (2010) 1.09

Alternative medicine research in clinical practice: a US national survey. Arch Intern Med (2009) 1.07

Risks and benefits associated with novel phase 1 oncology trial designs. Cancer (2007) 1.07

The future of the orthopaedic clinician-scientist: part II: Identification of factors that may influence orthopaedic residents' intent to perform research. J Bone Joint Surg Am (2010) 1.06

Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant (2005) 1.06

Beneficent persuasion: techniques and ethical guidelines to improve patients' decisions. Ann Fam Med (2010) 1.05

The dead-donor rule and the future of organ donation. N Engl J Med (2013) 1.05

Relationship between treatment preference and weight loss in the context of a randomized controlled trial. Obesity (Silver Spring) (2011) 1.04

Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection. Clin J Am Soc Nephrol (2010) 1.03

Using Behavioral Economics to Design Physician Incentives That Deliver High-Value Care. Ann Intern Med (2015) 1.01

Clarifying confusions about coercion. Hastings Cent Rep (2005) 1.01

Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiol Drug Saf (2012) 1.00

The allocation of intensivists' rounding time under conditions of intensive care unit capacity strain. Am J Respir Crit Care Med (2014) 0.98

Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis. BMJ (2004) 0.98